Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: J Urol. 2010 Jul 21;184(3):1204–1210. doi: 10.1016/j.juro.2010.04.066

Fig. 4.

Fig. 4

(A) GAD67 mRNA/β-actin mRNA ratio in L6-S1 DRG in HSV-LacZ and HSV-GAD-treated SCI rats. GAD67 mRNA/β-actin mRNA ratio in L6-S1 DRG was significantly increased in HSV-GAD-treated SCI rats compared with HSV-LacZ-treated SCI rats. Values are the mean ± SE. ** p<0.01 when compared between HSV-LacZ and HSV-GAD-treated SCI rats.